Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPOTLIGHT Smoking Cessation Trial
NCT03072511Phase 4Terminated
- Sponsor
- University of Florida
- Start
- Dec 2016
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Tobacco Use Disorder (TUD) (2 arms), sponsored by University of Florida. Primary endpoints: 7-day smoking point prevalence at 13 weeks and Delay Discounting at 13 weeks. Started Dec 2016; status: terminated.
02
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03072511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03072511.